EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring

Xin Meng Mekking, Kirsten Velthoven-Graafland, Marga J A Teulen, Roger J M Brüggemann iD, Lindsey H M Te Brake, Nynke G L Jager iD

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Xin Meng Mekking und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Utrecht University, Leuvenlaan 4, 3584 CE, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Floxacillin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop and validate an UPLC–MS/MS assay for simultaneous determination of the total concentration of ceftazidime, ciprofloxacin, flucloxacillin, piperacillin, tazobactam, sulfamethoxazole, N-acetyl sulfamethoxazole and trimethoprim, and the protein-unbound concentration of flucloxacillin, in human plasma to be used for research and clinical practice.

Methods

Sample pretreatment included protein precipitation with methanol. For the measurement of protein-unbound flucloxacillin, ultrafiltration was performed at physiological temperature. For all compounds, a stable isotopically labelled internal standard was used. Reliability of the results was assessed by participation in an international quality control programme.

Results

The assay was successfully validated according to the EMA guidelines over a concentration range of 0.5–100 mg/L for ceftazidime, 0.05–10 mg/L for ciprofloxacin, 0.4–125 mg/L for flucloxacillin, 0.2–60 mg/L for piperacillin, 0.15–30 mg/L for tazobactam, 1–200 mg/L for sulfamethoxazole and N-acetyl sulfamethoxazole, 0.05–10 mg/L for trimethoprim and 0.10–50 mg/L for unbound flucloxacillin. For measurement of total concentrations, the within- and between-day accuracy ranged from 90.0% to 109%, and 93.4% to 108%, respectively. Within- and between-day precision (variation coefficients, CVs) ranged from 1.70% to 11.2%, and 0.290% to 5.30%, respectively. For unbound flucloxacillin, within-day accuracy ranged from 103% to 106% and between-day accuracy from 102% to 105%. The within- and between-day CVs ranged from 1.92% to 7.11%. Results of the international quality control programme showed that the assay is reliable.

Conclusions

The method provided reliable, precise and accurate measurement of seven commonly prescribed antibiotics, including the unbound concentration of flucloxacillin. This method is now routinely applied in research and clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsFloxacillinHumansCeftazidimeChromatography, LiquidDrug MonitoringReproducibility of ResultsLiquid Chromatography-Mass SpectrometryTandem Mass SpectrometryPiperacillinTazobactamCiprofloxacinTrimethoprimSulfamethoxazoleChromatography, High Pressure Liquid

Substanzen

Anti-Bacterial AgentsFloxacillinCeftazidimePiperacillinTazobactamCiprofloxacinTrimethoprimSulfamethoxazole

Autor:innen und Institutionen

  • School of Pharmacy, Utrecht University, Leuvenlaan 4, 3584 CE, Utrecht, The Netherlands.
  • Department of Pharmacy, Radboud Institute for Medical Innovation, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.

ORCID-Profile: Roger J M Brüggemann, Nynke G L Jager

Zitieren

APA

Mekking, X. M., Velthoven-Graafland, K., Teulen, M. J. A., Brüggemann, R. J. M., Te Brake, L. H. M., & Jager, N. G. L. (2024). Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae047

Vancouver

Mekking XM, Velthoven-Graafland K, Teulen MJA, Brüggemann RJM, Te Brake LHM, Jager NGL. Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae047

BibTeX
@article{Mekking2024,
  author = {Mekking, Xin Meng and Velthoven-Graafland, Kirsten and Teulen, Marga J A and Brüggemann, Roger J M and Te Brake, Lindsey H M and Jager, Nynke G L},
  title = {Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae047}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche